| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.04B | 5.93B | 4.84B | 2.98B | 1.48B | 1.56B |
| Gross Profit | 2.71B | 2.69B | 2.39B | 1.35B | 553.36M | 699.13M |
| EBITDA | 788.12M | 723.27M | 797.93M | 509.91M | 187.51M | 375.40M |
| Net Income | -143.50M | -177.71M | -1.13B | -574.33M | 49.40M | 207.15M |
Balance Sheet | ||||||
| Total Assets | 8.09B | 8.19B | 7.69B | 8.67B | 6.66B | 6.55B |
| Cash, Cash Equivalents and Short-Term Investments | 1.41B | 3.15B | 2.74B | 3.80B | 3.66B | 5.55B |
| Total Debt | 1.93B | 2.05B | 1.40B | 1.50B | 0.00 | 0.00 |
| Total Liabilities | 2.83B | 2.99B | 2.55B | 2.59B | 219.21M | 143.50M |
| Stockholders Equity | 4.63B | 4.64B | 4.79B | 5.87B | 6.44B | 6.40B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 132.13M | 316.48M | 460.41M | 194.52M | -18.82M |
| Operating Cash Flow | 0.00 | 219.03M | 464.00M | 483.38M | 198.15M | 360.70M |
| Investing Cash Flow | 0.00 | -479.27M | -1.21B | -144.47M | -2.09B | -384.52M |
| Financing Cash Flow | 0.00 | 664.63M | -306.18M | -200.78M | 1.00K | 15.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥21.10B | 12.24 | ― | 0.82% | ― | ― | |
65 Neutral | ¥12.69B | 37.90 | ― | ― | 25.41% | 9.69% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥8.90B | 33.78 | ― | ― | 60.41% | -27.67% | |
56 Neutral | ¥3.89B | 35.15 | ― | ― | 10.43% | -65.78% | |
52 Neutral | ¥12.50B | -90.49 | ― | ― | 16.29% | 93.98% | |
44 Neutral | ¥22.60B | 35.20 | ― | ― | 36.08% | -7.71% |
HEROZ, Inc. released presentation materials for its FY04/2026 third-quarter financial results dated March 13, 2026, providing investors with an overview of its recent business performance. The document is identified as an excerpt translation from the original Japanese version, with the company clarifying that the Japanese text takes precedence in case of discrepancies, underscoring its primary regulatory and disclosure basis in Japan.
The most recent analyst rating on (JP:4382) stock is a Hold with a Yen769.00 price target. To see the full list of analyst forecasts on HEROZ, Inc. stock, see the JP:4382 Stock Forecast page.
HEROZ, Inc. reported consolidated net sales of ¥4.69 billion for the nine months ended Jan. 31, 2026, up 7.8% year on year, with EBITDA climbing 46.1% to ¥719 million and operating profit more than doubling to ¥358 million. Ordinary profit surged 189.8% to ¥265 million, and although the company still posted a net loss attributable to owners of the parent of ¥49 million, this represented a significant improvement from the ¥180 million loss a year earlier.
Total assets were broadly flat at ¥8.11 billion while net assets inched up to ¥5.38 billion, keeping the equity ratio stable at around 56%. For the full year to April 30, 2026, HEROZ forecasts net sales of ¥6.4 billion, a 7.9% increase, and expects operating profit of ¥500 million and ordinary profit of ¥420 million, signaling confidence in continued earnings recovery despite maintaining a zero-dividend policy.
The most recent analyst rating on (JP:4382) stock is a Hold with a Yen769.00 price target. To see the full list of analyst forecasts on HEROZ, Inc. stock, see the JP:4382 Stock Forecast page.
HEROZ, Inc. has entered into a business alliance with JPYC Inc., a Japanese issuer of electronic payment instruments tied to fund transfer services, and will take a stake in JPYC by subscribing to its Series B1 preferred shares via a third-party allotment. The partnership aims to embed HEROZ’s AI and AIX expertise into JPYC’s operations, with both companies set to collaborate on developing and implementing AI systems to streamline JPYC’s business and underpin new service offerings, while the capital tie-up is expected to deepen strategic cooperation and support medium- to long-term value creation for both sides.
The most recent analyst rating on (JP:4382) stock is a Hold with a Yen769.00 price target. To see the full list of analyst forecasts on HEROZ, Inc. stock, see the JP:4382 Stock Forecast page.